Preferred Label : End-point Assessment Medicinal Product;
NCIt definition : Medicinal products given to the subject as an aid to assess a relevant clinical trial
end-point; it is not being tested or used as a reference in the clinical trial. (Recommendations
from the expert group on clinical trials for the implementation of Regulation (EU)
No 536/2014' dd 28 June 2017);
Alternative definition : CDISC-GLOSS: Medicinal products given to the subject as an aid to assess a relevant
clinical trial end-point; it is not being tested or used as a reference in the clinical
trial. [After Recommendations from the expert group on clinical trials for the implementation
of Regulation (EU) No 536/2014' dd 28 June 2017];
NCI Metathesaurus CUI : CL979056;
Origin ID : C165826;
UMLS CUI : C5237467;
Semantic type(s)
- concept_is_in_subset
